Copper deficiency: the overlooked mineral behind cholesterol, fatty liver, and heart disease

Copper is not a mineral most people think about. If it comes up at all, it is usually in the context of anaemia or neurological symptoms, the kind of severe deficiency that gets flagged in a clinical setting and treated with a supplement. That framing misses the bigger picture.

Over the last decade of reading the research on metabolic health, copper is one of the minerals that kept appearing in places I did not expect: cholesterol metabolism, fatty liver, insulin resistance, heart disease. The connections are published in peer-reviewed research, but they rarely make it into the advice people actually receive.

When I was researching the mechanisms behind my own fatty liver and the metabolic dysfunction that led to gallbladder surgery at 46, copper was not on my radar. It should have been. The more I read, the more I see it connecting to the same metabolic picture I have spent years trying to understand.

Most of the conventional guidance on low copper focuses on the clinical end: anaemia, neurological problems, impaired immune function. Those are the effects that medical websites cover well. The metabolic effects, the ones that connect to the conditions people are actually struggling with, are largely absent from the conversation.

What copper actually does

Copper is a cofactor for enzymes involved in energy production, iron metabolism, antioxidant defence, and connective tissue formation. It is not a single-function mineral. It sits at the centre of several systems that affect how the body handles cholesterol, inflammation, and oxidative stress.

Two of the most relevant copper-dependent proteins are superoxide dismutase (SOD) and ceruloplasmin. SOD is one of the body's primary antioxidant enzymes, responsible for neutralising reactive oxygen species. Ceruloplasmin regulates iron metabolism, particularly in the liver. When copper is deficient, both are compromised, and the downstream effects are wider than most people realise.

Klevay, the researcher who first linked copper to cardiovascular disease in the 1970s, spent decades documenting how far the effects reach. In a historical review published in The Journal of Nutrition, he traced the evidence from early animal studies through to human data, showing that copper deficiency can produce elevated cholesterol, glucose intolerance, abnormal electrocardiograms, and hypertension. In a copper-deficient patient, SOD activity dropped to 52 percent of normal levels, reducing one of the body's primary defences against oxidative damage.

That is a broad set of effects from a single mineral being insufficient, and most of them connect directly to the metabolic conditions I write about on this site.

The signs most people recognise

If you search for signs of copper deficiency, you will find the same list on every medical website. Fatigue, anaemia, frequent infections, neurological symptoms like numbness or difficulty with balance, and changes in hair or skin pigmentation.

These are real and they can be serious. But they represent the far end of the spectrum, the point at which the body has run out of compensatory mechanisms. The question that interests me is what happens before that point, when copper intake is low enough to impair metabolic function but not low enough to produce the symptoms a doctor would recognise. That middle ground, the space between clinically deficient and genuinely optimal, is where the metabolic effects begin and where most of the population probably sits.

Dietary surveys consistently show that average copper intake in Western countries falls below the recommended dietary allowance. The RDA for copper sits at about 1 mg per day for adults, slightly higher for pregnant and lactating women, and most people do not meet it. Klevay estimated that only 25 percent of American diets contain the 2 mg of copper thought to be required daily, and other estimates suggest optimal intake may be closer to 2.6 mg per day, a figure few people come anywhere near. You can be well below optimal for years and never see it on a blood test, because serum copper is not routinely measured and does not reliably reflect tissue stores.

Copper, cholesterol, and your heart

This is where the standard clinical narrative stops and the research gets more interesting.

In 1978, Allen and Klevay published a study in Atherosclerosis showing that copper-deficient rats developed more than 50 percent increases in total cholesterol. The mechanism was upregulation of HMG-CoA reductase, the enzyme that controls cholesterol production in the liver. That is the same enzyme that statins are designed to inhibit.

The implication is worth sitting with. If insufficient copper drives up cholesterol production by upregulating the same enzyme that statins suppress, then at least some of what gets labelled as "high cholesterol" may be a mineral problem rather than a dietary fat problem.

A 2018 review in Open Heart pulled together decades of evidence and argued that low copper may be a leading cause of ischaemic heart disease, connecting it not only to elevated cholesterol but to LDL oxidation, reduced antioxidant capacity, and direct cardiovascular damage. When copper is insufficient, SOD activity drops, oxidative stress rises, and LDL particles become more susceptible to oxidation.

There is also a human intervention angle. A 2004 study in Archivos Latinoamericanos de Nutricion gave copper supplements to hyperlipidaemic patients and found measurable improvements in their lipid profiles, suggesting that the animal findings do translate to clinical relevance.

The science around lipid markers is contentious and still evolving. I have written about that elsewhere. But the copper connection adds a layer that rarely gets discussed. If a mineral deficiency is simultaneously driving cholesterol production up and reducing the antioxidant capacity that protects LDL from oxidation, the logical first step is addressing the deficiency, not prescribing a drug to suppress the enzyme that the deficiency is upregulating.

That is my reading of the evidence, not medical advice. But it is a line of research that, in my view, deserves far more attention than it currently receives. The research connecting copper to cholesterol has been in the literature since the late 1970s, and yet it does not feature in any of the mainstream advice people get when their cholesterol comes back high.

Copper deficiency and fatty liver

The liver connection runs through ceruloplasmin and iron.

Ceruloplasmin is the primary copper-containing protein in blood, and one of its main jobs is regulating iron metabolism. When copper is deficient, ceruloplasmin production drops. When ceruloplasmin drops, the liver loses its ability to export iron efficiently. Iron accumulates in liver cells, and that iron overload drives oxidative damage and fat accumulation.

A 2008 study published in Gastroenterology found that a significant proportion of patients with non-alcoholic fatty liver disease had low copper bioavailability, and that copper status was directly linked to iron perturbations in those patients. The authors concluded that low copper contributes to the iron dysregulation that characterises NAFLD.

I have written in detail about the fatty liver diet that worked for me and how insulin resistance, diet quality, and liver function connect. Copper adds another piece to that picture. If your liver is accumulating fat, and the advice you are getting is focused entirely on calories and exercise without ever looking at mineral status, there is a gap in the approach.

A 2010 study in The American Journal of Gastroenterology strengthened the case further. The researchers found that NAFLD patients had significantly lower hepatic copper concentrations than controls, and that restricting copper in rats reproduced the same pattern: hepatic steatosis and insulin resistance. The pathway is mechanistic, not just correlative.

The insulin resistance connection

Low copper also affects insulin sensitivity and glycation, both of which sit at the centre of metabolic disease.

Inadequate copper impairs glucose metabolism and promotes the formation of advanced glycation end-products (AGEs). AGEs are molecules formed when proteins or fats become glycated by sugars. They contribute to tissue damage, inflammation, and accelerated ageing. The same Aigner 2010 study that linked low hepatic copper to fatty liver also found that copper-restricted rats developed insulin resistance, connecting the two conditions through a shared mineral deficiency. A 2004 study in The Journal of Nutritional Biochemistry confirmed that both early and advanced glycation end-products are increased in dietary copper deficiency, providing direct evidence for the mechanism.

A 2019 review in Current Medicinal Chemistry examined the roles of zinc and copper in insulin resistance and diabetes, finding that both minerals influence insulin signalling and glucose homeostasis, and that imbalances between them can worsen metabolic outcomes.

The connection between copper, insulin, and glycation is less well known than the cholesterol connection, but it adds to the same picture. Copper deficiency does not just affect one metabolic pathway. It affects several of them simultaneously, and the combined effect is worse than any single pathway would suggest.

If you are dealing with blood sugar issues, copper is worth considering alongside the dietary changes and supplements that have stronger evidence for direct blood sugar management. It may not be the first thing to address. But in the context of someone who has cleaned up their diet and is still seeing elevated markers, mineral status, including the zinc-to-copper ratio, is a reasonable place to look.

The zinc problem nobody talks about

Zinc and copper compete for absorption in the gut. When zinc intake goes up without a corresponding increase in copper, copper status declines. This is well established in the research.

A 2015 review in the Journal of Clinical Pathology described the risk of copper deficiency in patients prescribed zinc supplements, finding that high-dose zinc supplementation can deplete copper stores over time and produce clinically significant deficiency.

This became especially relevant during and after COVID-19, when zinc supplementation became widespread. People were taking 30, 50, even 100 mg of zinc daily for extended periods, often without any copper to balance it. Zinc was marketed as immune support, and for many people it became a daily habit that persisted well beyond the pandemic. Research on zinc-induced copper depletion predates COVID by decades. A 1988 case report in Gastroenterology documented copper deficiency with anaemia, leukopenia, and neutropenia in a patient who had taken excessive oral zinc for ten months. But the scale of zinc supplementation in recent years has likely made the problem far more common than it was.

The zinc-to-copper ratio matters more than either mineral in isolation. A ratio of roughly 10:1 is where most of the research on safe supplementation sits. Someone taking 30 mg of zinc daily would want at least 2 to 3 mg of copper alongside it. Most people supplementing zinc are not doing this, and most of them have never been told to.

Why most people are not getting enough

The recommended dietary allowance for copper is about 1 mg per day for most adults, with pregnant and lactating women needing more. Some researchers have argued that optimal intake is closer to 2.6 mg per day, and most people in Western countries do not consume even the lower figure.

Copper-rich foods, particularly organ meats, shellfish, and dark chocolate, have largely disappeared from modern diets. Processed food tends to be copper-depleted, and refined grains lose most of their copper content during milling. Over the last century, the shift from whole food to industrial food has removed copper from the food supply in the same way it has removed many other minerals and micronutrients.

This is part of a pattern I keep seeing. The dietary advice most people follow steers them toward processed grains, lean meats, and low-fat products, while the foods that actually contain the minerals the body needs, liver, shellfish, full-fat dairy, nuts, have been pushed to the margins or dismissed entirely.

If your diet is built around processed food and refined carbohydrates, low copper intake is not surprising. It is predictable. And if you are also supplementing zinc without copper, which many people are, you are compounding the problem from both directions: lower intake and reduced absorption.

Where copper comes from

The richest dietary sources of copper are the same foods that traditional populations ate routinely and that modern diets have largely abandoned.

Beef liver is the single richest source. A 100-gram serving provides roughly 12 mg of copper, well above the RDA in a single meal. Oysters, dark chocolate, shiitake mushrooms, cashews, and sunflower seeds are also substantial sources.

This fits the ancestral approach to eating that I have written about. Whole foods are nutrient-dense in ways that processed alternatives simply are not. Organ meats in particular were prized by traditional cultures, not as occasional novelties but as dietary staples. Weston Price documented this across populations on multiple continents in the 1930s. Every healthy traditional population he studied was eating nutrient-dense animal foods, often including organ meats. Our modern aversion to these foods is a cultural shift, not a nutritional one.

If you are eating a whole-food diet that includes liver occasionally, some dark chocolate, nuts, and shellfish when available, copper intake tends to take care of itself. If you are eating processed food, it does not. And most people eating a modern Western diet are eating far more processed food than they realise.

What I would actually do about it

Food comes first. It always does. A diet built around whole foods, one that includes liver, dark chocolate, nuts, and shellfish, provides copper alongside all of the cofactors that support its absorption and utilisation. That is the same principle I come back to with every mineral and every supplement I write about. I have written about what foundational health actually means and why the dietary base has to be in place before anything else makes sense.

If you are supplementing zinc, balance it with copper. The research consistently shows that zinc without copper creates the conditions for depletion. A zinc-to-copper ratio of roughly 10:1 is a reasonable starting point based on the literature. If you are taking 30 mg of zinc, 2 to 3 mg of copper alongside it is a sensible minimum.

For someone who is not eating organ meats, shellfish, or other copper-rich foods regularly, a small copper supplement may be worth considering. The doses I have seen in the literature are modest, typically 1 to 3 mg per day. But the goal should be getting copper from food where possible, because whole food provides copper in a matrix of other minerals and cofactors that isolated supplements do not replicate. Supplementation is a stopgap, not a substitute for eating well.

Minerals like copper are not isolated variables. They interact with each other, with diet quality, and with metabolic function in ways that symptom-focused advice tends to miss. Copper connects to cholesterol, fatty liver, insulin resistance, and the stubborn visceral fat that most conventional advice cannot explain. The hormonal disruption that determines where fat is stored follows the same metabolic chain. These are not separate problems. They are expressions of a metabolic system that is not receiving the inputs it needs.

What keeps striking me about the copper research is how long the evidence has been there. The cholesterol connection was published in the 1970s, the fatty liver data in 2008 and 2010, the insulin resistance links across multiple decades. And yet, if you go to your doctor with high cholesterol, nobody checks your copper. If you are diagnosed with a fatty liver, nobody looks at your mineral status. The response is almost always the same: eat less, exercise more, and here is a prescription.

I keep coming back to the same observation across everything I write about. Treating the downstream number without asking what is driving it upstream is the pattern that conventional medicine falls into repeatedly. Copper is one more example of that pattern, and the research supporting the connection is stronger than most people realise.